FSHD Canada Foundation

CompanyCanada· Biotech

Canadian patient foundation funding research into FSHD muscular dystrophy.

Minutes holds 1 development naming FSHD Canada Foundation, recorded from September 2026.

Activity

FSHD Canada Foundation

Drug developer Satellos wins FDA clearance to trial forazapadin in FSHD

RegulatorySatellos Bioscience, FSHD Canada Foundation, +1Biotech24 SepGlobeNewswire

Elsewhere in Biotech

Past 3 months in Activity →

BioNTech says its mRNA head and neck cancer therapy missed a trial objective

BioNTechBiotech13 OctBioPharma Dive

Biotech Rewind Therapeutics secures financing for oral remyelination program

Deal · FundingRewind TherapeuticsBiotech6 OctGlobeNewswire